Cooper AJ - Search Results

1

Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain.

Kim SY, Marekov L, Bubber P, Browne SE, Stavrovskaya I, Lee J, Steinert PM, Blass JP, Beal MF, Gibson GE, Cooper AJ. Kim SY, et al. Among authors: cooper aj. Neurochem Res. 2005 Oct;30(10):1245-55. doi: 10.1007/s11064-005-8796-x. Neurochem Res. 2005. PMID: 16341586

2

Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria.

Krasnikov BF, Kim SY, McConoughey SJ, Ryu H, Xu H, Stavrovskaya I, Iismaa SE, Mearns BM, Ratan RR, Blass JP, Gibson GE, Cooper AJ. Krasnikov BF, et al. Among authors: cooper aj. Biochemistry. 2005 May 31;44(21):7830-43. doi: 10.1021/bi0500877. Biochemistry. 2005. PMID: 15909997 Free PMC article.

3

Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?

Cooper AJ, Jeitner TM, Gentile V, Blass JP. Cooper AJ, et al. Neurochem Int. 2002 Jan;40(1):53-67. doi: 10.1016/s0197-0186(01)00058-4. Neurochem Int. 2002. PMID: 11738472 Review.

4

Expression in Escherichia coli and purification of hexahistidine-tagged human tissue transglutaminase.

Shi Q, Kim SY, Blass JP, Cooper AJ. Shi Q, et al. Among authors: cooper aj. Protein Expr Purif. 2002 Apr;24(3):366-73. doi: 10.1006/prep.2001.1587. Protein Expr Purif. 2002. PMID: 11922752

5

Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases.

Cooper AJ, Wang J, Pasternack R, Fuchsbauer HL, Sheu RK, Blass JP. Cooper AJ, et al. Dev Neurosci. 2000 Sep-Dec;22(5-6):404-17. doi: 10.1159/000017470. Dev Neurosci. 2000. PMID: 11111157

6

A sensitive fluorometric assay for tissue transglutaminase.

Jeitner TM, Fuchsbauer HL, Blass JP, Cooper AJ. Jeitner TM, et al. Among authors: cooper aj. Anal Biochem. 2001 May 15;292(2):198-206. doi: 10.1006/abio.2001.5040. Anal Biochem. 2001. PMID: 11355851

7

N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.

Jeitner TM, Bogdanov MB, Matson WR, Daikhin Y, Yudkoff M, Folk JE, Steinman L, Browne SE, Beal MF, Blass JP, Cooper AJ. Jeitner TM, et al. Among authors: cooper aj. J Neurochem. 2001 Dec;79(5):1109-12. doi: 10.1046/j.1471-4159.2001.00673.x. J Neurochem. 2001. PMID: 11739625 Free article.

8

Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain.

Makar TK, Cooper AJ, Tofel-Grehl B, Thaler HT, Blass JP. Makar TK, et al. Among authors: cooper aj. Neurochem Res. 1995 Jun;20(6):705-11. doi: 10.1007/BF01705539. Neurochem Res. 1995. PMID: 7566367

9

Glyceraldehyde 3-phosphate dehydrogenase abnormality in metabolically stressed Huntington disease fibroblasts.

Cooper AJ, Sheu KF, Burke JR, Strittmatter WJ, Blass JP. Cooper AJ, et al. Dev Neurosci. 1998;20(4-5):462-8. doi: 10.1159/000017344. Dev Neurosci. 1998. PMID: 9778585

10

Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.

Cooper AJ, Sheu KF, Burke JR, Strittmatter WJ, Gentile V, Peluso G, Blass JP. Cooper AJ, et al. J Neurochem. 1999 Mar;72(3):889-99. doi: 10.1046/j.1471-4159.1999.0720889.x. J Neurochem. 1999. PMID: 10037459 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters